Abstract
The material derived from defective degradation of glycoproteins, which accumulates in brain and liver of a patient with GM1 gangliosidosis type I, was investigated, and the structure of the main storage compounds determined.
For comparison, brain and liver of a patient with GM1 gangliosidosis type II were also analyzed.
Analysis of the glycopeptides obtained after pronase digestion of the defatted residue indicates the storage of glycoprotein-like material in type I, but not in type II. Treatment with endo-β-galactosidase showed that the stored material containedN-acetyllactosamine repeating units.
Two major oligosaccharides, OS I and OS II, were isolated after the enzyme treatment, whose structures are: GlcNAcβ1→3 Gal (OS I) and Galβl→4GlcNAcβ1→3 Gal (OS II).
Treatment with exo-β-galactosidase transformed the trisaccharide OS II into the disaccharide OS I, indicating that the deficiency of β-galactosidase in GM1 gangliosidosis type I, but not in type II, also affects glycoprotein catabolism, leading to the accumulation of glycopeptides containing terminal β-galactosyl residues andN-acetyllactosamine repeating units.
These results indicate the severe impairment in the catabolism of glycoconjugates with β-linked galactose in type I, although this impairment is not as pronounced in type II.
Similar content being viewed by others
References
Berra B., Di Palma S., and Brunngraber E. G. (1974) Altered levels of tissue gangliosides and glycoproteins in the infantile form of GM1 gangliosidosis.Clin. Chim. Acta 57, 301–306.
Bhatti, T., Chambers, R. E., and Clamp, J. R. (1970) The gas chromatographic properties of biologically important N-acetylglucosamine derivatives, monosaccharides, disaccharides, trisaccharides, tetrasaccharides, and pentasaccharides.Biochim. Biophys. Acta 222, 339–347.
Di Palma S., Berra B., Li Y. T., and Li S. C., (1978) Storage of glycoproteins containing terminal galactose in brain of two patients with type I GM1 gangliosidosis, inPerspectives in Inherited Metabolic Diseases, vol. 1, pp. 155–164. Edi-Ermes, Milano.
Dubois M., Gilles K. A., Hamilton, J. K., Rebers, P. A., and Smith F. (1956) Colorimetric determination of sugars and related substances.Anal. Chem. 28, 350–356.
Harris G. and MacWilliam J. C. (1954) Dipping technique for revealing neutral sugars on paper chromatography.Chem. Ind. (London) pp. 249.
Jarnefelt J., Rush J., Li Y. T., and Laine R. (1978) Erythroglycan, a high molecular weight glycopeptide with the repeating structure galactosyl (1→4)-2-deoxy-2-acetamido-glucosyl (1→3) comprising more than onethird of the protein bound carbohydrates of human erythrocyte stroma.J. Biol. Chem. 253, 8006–8009.
Li Y. T. and Li S. C. (1972) Degradation of complex carbohydrates, section VI, inMethods in Enzymology, vol. 28, (Ginsburg V., ed.) pp. 702–713, Academic, NY, NY.
Nakagawa H., Yamada T., Chien J. L., Gardas A., Kitamikado M., Li S. C., and Li Y. T. (1980) Isolation and characterization of an endo-β-galactosidase from a new strain ofEscherichia freundii.J. Biol. Chem. 255, 5955–5959.
O’Brien J. (1983) The Gangliosidoses, in the Metabolic Basis of Inherited Disease (Stanbury J. B., Wyngaarden J. B., Fredrickson D. S., Goldstein M. D., and Brown M. D. eds) pp. 945–969, McGraw Hill, New York.
Ohkura T., Yamashita K., Kobata A. (1981) Urinary oligosaccharides of GM1 gangliosidosis. Structures of oligosaccharides excreted in the urine of type I but not in the urine of type II patients.J. Biol. Chem. 256, 8485–8490.
Suzuki K. and Kamoshita S. (1969) Chemical pathology of GM1 gangliosidosis (generalized gangliosidosis).J. Neuropathol. Exp. Neurol. 28, 25–73.
Tettamanti G., Bonali F., Marchesini S., and Zambotti V. (1973) A new procedure for extraction, purification, and fractionation of brain gangliosides.Biochim. Biophys. Acta 296, 160–170.
Tsay G. C., Dawson G., and Li Y. T. (1975) Structure of the glycopeptide storage material in GM1 gangliosidosis. Sequence determination with specific endo- and exo-glycosidases.Biochim. Biophys. Acta 385, 305–311.
Yamashita K., Ohkura T., Okada S., Yabuuchi H., and Kobata A. (1981) Urinary oligosaccharides of GM1-gangliosidosis. Different excretion patterns of oligosaccharides in the urine of type I and II subgroups.J. Biol. Chem. 256, 4789–4798.
Yutaka T., Okada S., Minaki K., Sugita T., and Yabuuchi H. (1975) Enzymatic study of GM1 gangliosidosis.Clin. Chim. Acta 59, 283–290.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berra, B., De Gasperi, R., Rapelli, S. et al. Presence of glycoproteins containing the polylactosamine structure in brain and liver of GM1 gangliosidosis patients. Neurochemical Pathology 4, 107–117 (1986). https://doi.org/10.1007/BF03160189
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03160189
Index Entries
- GM1 gangliosidosis, types I and II
- glycoprotein storage diseases
- polylactosamine type glycoproteins
- glycoprotein degradation, defective, materials derived from
- glycoprotein catabolism, effects of β-galactosidase deficiency in GM1 gangliosidosis type I on
- glycoconjugates, impairment in catabolism of
- N-acetyl-lactosamine